Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

Study shows plasmacytoid dendritic cells may be a viable target for protection against SARS-CoV-2

A recent research paper by scientists from Denmark reveals that circulating plasmacytoid dendritic cells may be a potential therapeutic target to maintain desired levels of an antiviral compound known as interferon, allowing for the mitigation of coronavirus disease (COVID-19) severity. The study is currently available on the bioRxiv* preprint server while it undergoes peer review.

28 Nov 2021

An analysis of SARS-CoV-2 breakthrough infections by variant and vaccine

Researchers compared the distribution of SARS-CoV-2 genotypes to the prevalence of SARS-CoV-2 variants.

28 Nov 2021

Study finds no evidence to support favipiravir use in mild or asymptomatic COVID-19 patients

Researchers conducted a Phase II randomized placebo-controlled, double-blinded trial between July 8, 2020, and March 23. 2021.

28 Nov 2021

Using dried blood spots to monitor SARS-CoV-2 antibodies at home

The Roche Elecsys® anti-SARS-CoV-2 S immunoassay was used to demonstrate its ability to measure SARS-CoV-2 antibodies from DBS samples.

28 Nov 2021

How often does SARS-CoV-2 infect alongside another viruses?

Researchers have been exploring data from COVID-19 patients tested at hospitals or clinics that also look for evidence of other diseases.

28 Nov 2021

The introduction and rapid spread of SARS-CoV-2 Gamma in Venezuela

Researchers from the Instituto Venezolano de Investigaciones Científica investigate the introduction of one of the VOCs into Venezuela.

28 Nov 2021

Vaccination provides full protection against severe outcomes of COVID-19 among U.S. Coast Guard

Researchers performed a time-series analysis to evaluate the effectiveness of COVID-19 vaccination in the U.S. CG against SARS-CoV-2 infection.

28 Nov 2021

Seroprevalence study reveals high exposure to SARS-CoV-2 in Bangui population

Researchers performed a cross-sectional study in the city of Bangui, the capital of the Central African Republic from July 12, 2021, to August 20, 2021.

28 Nov 2021

SARS-CoV-2 Omicron variant: What we know so far

On November 24, 2021, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron (B.1.1.529) variant was first reported to the World Health Organization (WHO) from South Africa.

28 Nov 2021

Prediction of severe infection based on SARS-CoV-2 genomic analysis

A group of researchers have used these SARS-CoV-2 sequence data and developed an algorithm to predict severity based upon viral mutations.

26 Nov 2021

Multi-generational household clusters during COVID-19 pandemic in England

The research team aimed to validate a previous hypothesis on multi-generational households as a prime contributor to the overall number of COVID-19 cases during the Summer of 2020.

26 Nov 2021

Effects of social class, ethnicity, and gender on burden of COVID-19 mortality

The researchers determined if opportunities for remote work correlated with COVID-19 deaths for sociodemographic groups.

26 Nov 2021

Efficacy and safety of an RBD-based recombinant protein COVID-19 vaccine

A study developed a protein-based subunit vaccine, PHH-1V, that consisted of a recombinant RBD fusion heterodimer of the alpha) and beta variants of SARS-CoV-2.

26 Nov 2021

Antiviral activity of a photoactivable natural product on coronaviruses

A new study showed that pheophorbide a has antiviral activity against many CoVs.

26 Nov 2021

SARS-CoV-2 vaccine based on vesicular stomatitis virus exhibits high neutralizing efficacy against variants

Scientists have tested the efficacy of BriLife®-vaccinated human sera in neutralizing more infectious and probably more virulent SARS-CoV-2 variants.

26 Nov 2021

Post-discharge healthcare use of pediatric COVID-19 patients compared to pediatric RTIs patients

Researchers explored whether, and for how long, hospital contacts due to COVID-19 resulted in an increase in individual health care use, compared to hospital contacts with RSV infection and other RTIs.

26 Nov 2021

A review of natural immunity, vaccines, and variants in SARS-CoV-2 reinfection

In a literature review article published in the Journal of Community Hospital Internal Medicine Perspectives, authors from the US performed a thorough investigation of previous studies and case reports of SARS-CoV-2 reinfection. This review discusses the role of natural immunity, vaccines, and SARS-CoV-2 variants in reinfection.

25 Nov 2021

Triple combination symptoms anosmia-fatigue-cough more specific to COVID-19 than single symptoms

In a research paper published in the journal PLOS ONE, the authors developed COVID–Online, a symptom checking application in Germany.

25 Nov 2021

Study explores adverse effects of SARS-CoV-2-induced antibody responses

The authors of a research paper published in the journal Frontiers in Immunology used Sandwich ELISA tests to determine the distribution of IgG sub-classes and complement activation levels in plasma from convalescent individuals.

25 Nov 2021

Key to controlling COVID-19 is early intervention

A study published in the journal Royal Society Open Science demonstrates the critical role of timely intervention in New Zealand's success story. The researchers used a stochastic branching process model to simulate the trajectory of COVID-19 transmission and control during New Zealand's 2020 outbreak. They calculated the number of reported cases and deaths and the probability of elimination within a defined time frame.

25 Nov 2021